3rd RSC / SCI / SEQT Symposium on
Medicinal Chemistry for Global Health
Wednesday-Friday, 24th-26th June 2020
GlaxoSmithKline, Tres Cantos, Madrid, Spain
Registration is open
Twitter hashtag - #MCGH20
|Downloads and Links|
Oral abstract template - final closing date is 24th April
Early submission is encouraged because spaces are limited and speaker slots are being allocated on a case-by-case basis.
Tuberculosis, malaria and diseases caused by a diverse range of pathogens, including flaviviruses (eg dengue, West Nile), kinetoplastids (causative agents of Chagas disease, leishmaniasis, etc) and gut pathogens (worms, bacteria, parasites), remain a cause of high mortality across the globe. Fortunately, an ever-improving understanding of the complex life-cycles of these disease-causing pathogens is presenting increasing opportunities for those seeking to tackle these global health problems.
Who should attend?
Call for Abstracts
Abstracts are invited for short oral presentations, and the final closing date for abstract submission is 24th April. Early submission is encouraged because spaces are limited and speaker slots are being allocated on a case-by-case basis.
Please download an abstract template here.
Antibiotic destruction by its target and the limits of irreversible inhibition
Luiz Carvalho, Francis Crick Institute, UK
KRS – a novel target for TB, exploited using structure-based drug design
Laura Cleghorn, Drug Discovery Unit, University of Dundee, UK
Novel oxazolidinone-class protein synthesis inhibitors with improved safety profiles
Brendan M Crowley, MSD, USA
NTM drug discovery at CDI
Thomas Dick, Hackensack Meridian Health, US
Pharmacological interventions for the treatment of enteric bacteria
Elena Fernández Alvaro, GlaxoSmithKline, ES
Identification of novel antimalarial chemopreventive therapies
María de Gracia Gomez, GlaxoSmithKline, ES
Plasmodium autophagy evasion in the liver-stage: mechanisms and novel therapeutic opportunities
María Mota, University of Lisbon, PT
Neglected tropical disease drug discovery through a combination of lead repurposing and distributed drug discovery
Michael Pollastri, Northeastern University, US
The energy metabolism of Leishmania as a drug target
Luis Rivas, CIB-CSIC (Biological Research Center of the Spanish National Research Council), ES
Results of the proof-of-concept study for the M72/AS01E tuberculosis vaccine candidate
Lode Schuerman, GlaxoSmithKline Vaccines, BE
A proteasome inhibitors story: from bench to bedside and back again
Florencia Segal, Novartis, US
What makes a good hit and how to get there – lessons learned from NTD hit generation beyond screening
Driving drug discovery for global health
Peter Warner, Bill and Melinda Gates Foundation, US
Combination therapy for a new treatment for Chagas disease?
Synthesis and evaluation of cyclopeptides containing N-methyl amino acids as promising antiplasmodial agents
Registration, Fees and Bursaries
Registration is open
Registration fees until 19th March:
* Student is undergraduate or post-graduate, not post-doc, and does not apply to students in paid employment.
Students may apply for a bursary to support registration, travel and accommodation costs, and the closing date for applications is 8th May. Download a bursary application form here.
Student members of the SEQT will receive a direct invitation from the SEQT to apply for a bursary to attend this event.
In the event of cancellation by 17th May 2020, 80% of the fee paid will be refunded. Cancellations must be received in writing. Refunds will not be possible after that date although substitutions are possible at any time. In the unlikely event of cancellation of the meeting, fees paid will be refunded in full.
The exhibition will be situated in a single area just outside of the lecture theatre, ensuring excellent access to delegates throughout the meeting.
The exhibition charge of £1,320 includes:
- one full delegate's attendance
- logo in rolling slides and delegate handbook
- single promotional page in printed delegate handbook
Delegate pack inserts may be booked at £200 - no more than two sheets of A4 fixed together.
Sponsors are encouraged to support this established event. Sponsorship will support the low registration fees being offered to students.
This event is organised jointly by the:
- Royal Society of Chemistry’s Biological and Medicinal Chemistry Sector (RSC BMCS)
We are grateful to EFMC for supporting this event
Venue and Travel
Address: Trelegy Auditorium, GlaxoSmithKline, Technology Park of Madrid, C / Severo Ochoa 2, 28760 - Tres Cantos, Madrid, Spain
Air: Madrid airport (Adolfo Suárez Madrid-Barajas) has a railway station at Terminal 4. A free shuttle bus runs from outside Terminals 1, 2 and 3 to Terminal 4.
Rail: Airport to Tres Cantos with one change at Chamartin station: less than 1 hour. Airport to Madrid Atocha central railway station: 25 minutes. Service provider is Renfe Cercanías. Download a plan of the railway routes here.
Taxi: Airport to Tres Cantos costs about €50: 30 minutes.
Car: A limited number of car parking spaces is available on site at GSK and these will be allocated on a "first come, first served" basis. Please book your car parking as part of the registration process and provide your vehicle's registration number.
We have held a limited number of rooms with two hotels in Tres Cantos at preferential rates as below.
Maggi Churchouse Events, 3 East Barn, Market Weston Road, Thelnetham, Diss IP22 1JJ, UK
Telephone: +44 (0)1359 221004